Real-World Outcomes With Inetetamab-Based Regimens for HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Analysis in China
基于伊奈妥单抗方案治疗HER2阳性转移性乳腺癌的真实世界疗效:一项中国多中心回顾性分析
期刊:Cancer Control
影响因子:2.6
doi:10.1177/10732748261419187
Zheng, Fangchao; Zhang, Jiale; Zhou, Dongdong; Ren, Guohua; Qiang, Ling; Wang, Ting; Pan, Fei; Shan, Changping; Xia, Chongsheng; Yang, Fan; Wang, Hongjian; Liu, Guozhu; Wang, Jingfen; Hua, Ruimin; Du, Xin; Zhang, Baoxuan; Li, Huihui